Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / NGMD:CC - NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic

NGMD:CC - NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic

Nugen Medical Devices Inc.

--News Direct--

NuGen Medical Devices executive chairman Tony Di Benedetto joined Steve Darling from Proactive to provide details about the company that is developing the next generation of needle-free technologies for both humans and animals.

Di Benedetto shares with Proactive more about the technology behind products InsuJet and PetJet and also about an assessment and feasibility study in the Netherlands of InsuJet for Semaglutide or its more widely known name Ozempic.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/nugen-medical-devices-begins-feasibility-study-in-the-netherlands-for-insujet-and-ozempic-884076141

Stock Information
Company Name: Nugen Medical Devices Inc.
Stock Symbol: NGMD:CC
Market: TSXVC
Website: nugenmd.com
Menu
NGMD:CC NGMD:CC Quote NGMD:CC Short NGMD:CC News NGMD:CC Articles NGMD:CC Message Board
Get NGMD:CC Alerts

News, Short Squeeze, Breakout and More Instantly...